10x Genomics Inc’s effort to develop a COVID19 treatment halted due to ransomware attack
https://www.cyberscoop.com/covid-19-ransomware-10x-genomics-data-breach/
Exploit: Ransomware
10x Genomics Inc.: Biotechnology company
Risk to Small Business: 2.206 = Severe: A ransomware attack disrupted operations at the biotechnology company, which is currently acting as part of a consortium working to quickly develop a treatment for COVID-19. Before encrypting IT, hackers exfiltrated company data. Although the company reports “no material day-to-day impact,” it’s unclear what the implications are for the stolen data or how this could impact its development of a COVID-19 treatment.
Individual Risk: At this time, no personal information was compromised in the breach.
Customers Impacted: Unknown
How it Could Affect Your Customers’ Business: Companies in every sector have seen an uptick in cybersecurity threats as COVID-19 disrupts business-as-usual and puts many people on edge. This is especially true for the healthcare industry, which is experiencing a deluge of ransomware attacks, phishing scams, and other threats at a critical time.
Risk Levels:
1 - 1.5 = Extreme Risk
1.51 - 2.49 = Severe Risk
2.5 - 3 = Moderate Risk
*The risk score is calculated using a formula that considers a wide range of factors related to the assessed breach.
